Rocket Pharmaceuticals In...
10.89
0.46 (4.41%)
At close: Jan 15, 2025, 1:44 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Cash & Equivalents 55.90M 140.52M 232.69M 297.10M 185.38M 111.36M 78.72M 29.80M 80.04M 3.62M 12.79M 1.37M
Short-Term Investments 317.27M 215.88M 156.05M 185.62M 118.73M 94.38M 21.29M 96.67M 31.24M n/a n/a n/a
Long-Term Investments 34.32M 43.28M 1.34M 1.57M 1.52M 7.40M 207.00K n/a n/a n/a n/a n/a
Other Long-Term Assets 1.91M 1.95M 1.80M 2.02M 1.98M 1.44M -39.00K 168.00K 143.00K 1.90M 4.00K 4.00K
Receivables n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 5.05M 7.67M 6.64M 9.25M 7.28M 6.72M 1.03M 1.88M 2.17M 104.00K 66.00K 45.00K
Total Current Assets 378.22M 364.06M 392.06M 487.35M 307.75M 209.09M 101.05M 128.35M 112.37M 3.62M 12.86M 1.42M
Property-Plant & Equipment 87.59M 77.64M 72.35M 70.64M 31.35M 2.03M 563.00K 1.13M 812.00K n/a n/a n/a
Goodwill & Intangibles 64.30M 64.88M 30.82M 30.82M 31.04M 30.82M n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 188.12M 187.75M 104.96M 103.48M 64.37M 42.23M 731.00K 1.30M 955.00K 1.90M 4.00K 4.00K
Total Assets 566.34M 551.81M 497.02M 590.82M 372.12M 251.31M 101.78M 129.65M 113.32M 5.52M 12.86M 1.42M
Account Payables n/a n/a n/a n/a n/a n/a 451.00K 1.59M 1.63M 1.15M 229.00K 387.00K
Deferred Revenue n/a -36.66M -482 590.00K 562.00K 534.00K 506.00K 478.00K 450.00K 421.00K 394.00K 367.00K
Short-Term Debt 2.72M 5.02M 5.10M 9.41M 1.91M n/a n/a n/a n/a 5.08M 693.00K 2.21M
Other Current Liabilities 45.79M 34.15M 17.06M 23.20M 16.39M 15.37M 3.11M 5.62M 2.51M -2.53M 1.19M 298.00K
Total Current Liabilities 48.51M 39.17M 22.17M 32.62M 18.31M 15.37M 4.07M 7.21M 4.14M 3.70M 3.22M 3.77M
Long-Term Debt 22.33M 40.71M 40.10M 74.04M 47.94M 41.45M 49.54M 48.96M n/a 2.55M 5.39M n/a
Other Long-Term Liabilities 2.94M -17.76M -19.97M -19.35M -1.42M 457.00K 403.00K 307.00K 367.00K 50.83M 43.15M 28.59M
Total Long-Term Liabilities 25.26M 22.95M 20.13M 54.69M 46.52M 41.90M 49.94M 49.27M 367.00K 53.38M 48.54M 28.59M
Total Liabilities 73.77M 62.12M 42.30M 87.31M 64.82M 57.28M 54.01M 56.48M 4.51M 57.08M 51.76M 32.35M
Total Debt 25.04M 22.87M 22.60M 61.70M 47.45M 41.45M 49.54M 48.96M 14.00 7.15M 6.80M 2.71M
Common Stock 903.00K 791.00K 645.00K 610.00K 548.00K 452.00K 68.00K 270.00K 264.00K 10.00K 10.00K 10.00K
Retained Earnings -959.37M -713.77M -491.91M -322.84M -183.14M -105.87M -268.37M -238.88M -196.02M -128.04M -118.51M -110.89M
Comprehensive Income 319.00K -357.00K -161.00K -42.00K 20.00K -127.00K -16.00K -54.00K -11.00K -217.00K -217.00K -217.00K
Shareholders Equity 492.57M 489.69M 454.72M 503.52M 307.30M 194.04M 47.76M 73.17M 108.81M -51.56M -38.90M -30.93M
Total Investments 351.59M 259.15M 156.05M 185.62M 118.73M 101.78M 21.29M 96.67M 31.24M n/a n/a n/a